Education

  • Perelman School of Medicine at the University of Pennsylvania - MD
  • Hospital of the University of Pennsylvania - Residency in Internal Medicine
  • University of California, San Francisco - Fellowship in Pulmonary and Critical Care
  • University of Pennsylvania - MS in Translational Research

Professional Activities

Dr. Faust is a faculty member in the Division of Allergy, Pulmonary and Critical Care Medicine. She is physician-scientist focused on investigating the role of endothelial dysfunction in sepsis and acute respiratory distress syndrome (ARDS), with a focus on translational mechanisms and therapeutic discovery. She is currently supported by a K08 Mentored Clinical Scientist Development Award from NIGMS/NIH. She was previously a KL2 Scholar through the Institute for Clinical and Translational Research (ICTR) at UW. 

Past honors include a Star Clinican Award (2024) and Star Clinican Award (2021, 2024) from the UW Department of Medicine, the Society for Critical Care Medicine Silver Snapshot Award and Internal Medicine Section Travel Grant, and the Vox Sanguinis Best Paper Prize 2020. She co-teaches a UW School of Medicine and Public Health course for medical students (Body in Balance) as well as the Ventilator Simulation Curriculum and multiple lectures for the UW Pulmonary and Critical Care Fellowship. She is a member of the Trauma and Life Support Center (TLC) Quality Improvement Committee.

Clinical Specialties

Dr. Faust's clinical interests include ARDS, sepsis, mechanical ventilation, ECMO, ICU liberation, and quality improvement.

Research Interests

View Dr. Hilary Faust's publications on NCBI MyBibliography.

Dr. Faust studies the role of endothelial dysfunction in sepsis in critically ill patients to discover biomarkers of injury mechanisms and biological subphenotypes. Specific interests include role of damage-associated molecular patterns such as cell-free nucleic acids in precipitating endothelial dysfunction and how this mechanism contributes to the pathophysiology of lung and kidney injury as well as use of human cellular models such as microphysiological systems to model human pathophysiology. Her long-term goal is to identify mechanistically-based subphenotypes of ARDS and AKI that may facilitate development of targeted treatments and precision medicine approaches to critically ill patients.

Submit bio updates